लोड हो रहा है...
Belatacept for the prophylaxis of organ rejection in kidney transplant patients: an evidence-based review of its place in therapy
BACKGROUND: Belatacept is a novel immunosuppressive therapy designed to improve clinical outcomes associated with kidney transplant recipients while minimizing use of calcineurin inhibitors (CNIs). METHODS: We searched for clinical trials related to administration of belatacept to kidney transplant...
में बचाया:
में प्रकाशित: | Int J Nephrol Renovasc Dis |
---|---|
मुख्य लेखकों: | , , |
स्वरूप: | Artigo |
भाषा: | Inglês |
प्रकाशित: |
Dove Medical Press
2016
|
विषय: | |
ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4888760/ https://ncbi.nlm.nih.gov/pubmed/27307759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJNRD.S88816 |
टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|